Product
  • Product
  • Supplier
  • Inquiry

    EN

    Home > Chemial News > Pharma News > Hikal: Successfully developed Fapiravir APIs and intermediates

    Hikal: Successfully developed Fapiravir APIs and intermediates

    Echemi 2020-06-22

    Indian pharmaceutical intermediate and API manufacturer Hikal Limited (Hikal Limited) announced on June 19 that it has successfully developed Favipiravir API and its intermediates.

    Fapiravir is a generic drug of Avigan, a drug of Toyama Chemical, a subsidiary of Fujifilm Corporation in Japan. The drug has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of new influenza virus infections. At present, in many countries, piravir is in different stages of clinical trials for the treatment of new coronavirus pneumonia.

    It is reported that Hikal is negotiating with potential partners on the supply of the finished medicine.

    Share to:
    Disclaimer: Echemi reserves the right of final explanation and revision for all the information.

    Scan the QR Code to Share

    Suggestions
    Email:
    Message:
    Send Message